相似文献
1
Effective, nonsensitizing vaccination with culture filtrate proteins against virulent Mycobacterium bovis infections in mice.
Infect Immun. 1998 Oct;66(10):5048-51. doi: 10.1128/IAI.66.10.5048-5051.1998.
2
Effect of different adjuvants on the immune responses of cattle vaccinated with Mycobacterium tuberculosis culture filtrate proteins.
Vet Immunol Immunopathol. 2002 May;86(1-2):79-88. doi: 10.1016/s0165-2427(02)00017-x.
3
Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone.
Clin Vaccine Immunol. 2008 May;15(5):765-72. doi: 10.1128/CVI.00034-08. Epub 2008 Mar 12.
4
Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosis.
Infect Immun. 2000 Oct;68(10):5809-15. doi: 10.1128/IAI.68.10.5809-5815.2000.
5
Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone.
Infect Immun. 2005 Jun;73(6):3540-6. doi: 10.1128/IAI.73.6.3540-3546.2005.
6
Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis.
Vet Immunol Immunopathol. 2005 Jun 15;106(1-2):53-63. doi: 10.1016/j.vetimm.2005.01.002.
7
Intranasal BCG vaccination protects BALB/c mice against virulent Mycobacterium bovis and accelerates production of IFN-gamma in their lungs.
Clin Exp Immunol. 2001 Nov;126(2):274-9. doi: 10.1046/j.1365-2249.2001.01667.x.
8
Protection against bovine tuberculosis induced by oral vaccination of cattle with Mycobacterium bovis BCG is not enhanced by co-administration of mycobacterial protein vaccines.
Vet Immunol Immunopathol. 2011 Dec 15;144(3-4):220-7. doi: 10.1016/j.vetimm.2011.09.005. Epub 2011 Sep 29.
9
Vaccination of mice and cattle with plasmid DNA encoding the Mycobacterium bovis antigen MPB83.
Clin Infect Dis. 2000 Jun;30 Suppl 3:S283-7. doi: 10.1086/313875.
10
Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine.
Infect Immun. 1999 Jun;67(6):2867-73. doi: 10.1128/IAI.67.6.2867-2873.1999.
引用本文的文献
1
TLR Agonist Augments Prophylactic Potential of Acid Inducible Antigen Rv3203 against Mycobacterium tuberculosis H37Rv in Experimental Animals.
PLoS One. 2016 Mar 29;11(3):e0152240. doi: 10.1371/journal.pone.0152240. eCollection 2016.
2
Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates.
Adv Drug Deliv Rev. 2016 Jul 1;102:73-82. doi: 10.1016/j.addr.2015.11.012. Epub 2015 Nov 17.
3
Proteomic analysis identifies highly antigenic proteins in exosomes from M. tuberculosis-infected and culture filtrate protein-treated macrophages.
Proteomics. 2010 Sep;10(17):3190-202. doi: 10.1002/pmic.200900840.
4
Mycobacterium tuberculosis conserved hypothetical protein rRv2626c modulates macrophage effector functions.
Immunology. 2010 May;130(1):34-45. doi: 10.1111/j.1365-2567.2009.03196.x. Epub 2010 Feb 26.
5
Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone.
Infect Immun. 2005 Jun;73(6):3540-6. doi: 10.1128/IAI.73.6.3540-3546.2005.
6
A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.
Infect Immun. 2003 Sep;71(9):4901-7. doi: 10.1128/IAI.71.9.4901-4907.2003.
7
A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
Immunology. 2003 Apr;108(4):548-55. doi: 10.1046/j.1365-2567.2003.01589.x.
8
Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosis.
Infect Immun. 2000 Oct;68(10):5809-15. doi: 10.1128/IAI.68.10.5809-5815.2000.
9
ESAT-6 subunit vaccination against Mycobacterium tuberculosis.
Infect Immun. 2000 Feb;68(2):791-5. doi: 10.1128/IAI.68.2.791-795.2000.
本文引用的文献
1
Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis.
Infect Immun. 1998 Jun;66(6):2951-9. doi: 10.1128/IAI.66.6.2951-2959.1998.
2
Adjuvant modulation of immune responses to tuberculosis subunit vaccines.
Infect Immun. 1997 Feb;65(2):623-9. doi: 10.1128/iai.65.2.623-629.1997.
3
Structure/function studies on QS-21, a unique immunological adjuvant from Quillaja saponaria.
Adv Exp Med Biol. 1996;404:165-72. doi: 10.1007/978-1-4899-1367-8_15.
4
Isomerization and formulation stability of the vaccine adjuvant QS-21.
J Pharm Sci. 1996 Jan;85(1):22-8. doi: 10.1021/js9503136.
5
Saponins as vaccine adjuvants.
Crit Rev Ther Drug Carrier Syst. 1996;13(1-2):1-55.
6
Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function.
Vaccine. 1995;13(15):1403-10. doi: 10.1016/0264-410x(95)00077-e.
7
Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae.
Res Vet Sci. 1995 Jul;59(1):10-6. doi: 10.1016/0034-5288(95)90023-3.
8
Disseminated tuberculosis in interferon gamma gene-disrupted mice.
J Exp Med. 1993 Dec 1;178(6):2243-7. doi: 10.1084/jem.178.6.2243.
9
Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins.
Infect Immun. 1994 Jun;62(6):2536-44. doi: 10.1128/iai.62.6.2536-2544.1994.
10
Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma.
Vaccine. 1994 Nov;12(14):1275-80. doi: 10.1016/s0264-410x(94)80052-2.
Zotero 插件